Medical shop sealed for illegal sale of psychotropic drugs

UDHAMPUR:  A joint team of officials from the Drug and Food Control Organisation Udhampur and the Police Department conducted regulatory inspections and sealed a medical shop for illegal sale of psychotropic drugs.

The inspections were initiated based on specific information regarding M/s D K Medicos, Airforce Road, Udhampur, which was allegedly involved in selling Schedule H1 drugs without following the mandatory procedures. Upon inspection, the proprietor Deep Kumar admitted to not maintaining any sale records via CBS (Centralized Billing System).

Following the violations observed under Section 22D of the Drugs and Cosmetics Act, 1940, the premises were sealed on the spot in the presence of police officials. A show-cause notice was issued to the proprietor.

The inspection team was led by Sanjeev Kumar Gupta, Assistant Drug Controller Udhampur/ Ramban, along with Drug Control Officers Rakesh Singh Slathia (Udhampur HQ) and Narinder Pravesh (Ramnagar). The police team was headed by SHO Raghuveer Singh, SI Abhinav Bhatti, and accompanying police personnel, including a lady constable.

Related Posts

  • Pharma
  • April 30, 2025
  • 89 views
Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

New Delhi:   The union health ministry has notified the Drugs & Cosmetics (Compounding of Offences) Rules 2025 to allow minor offences to be settled by fine or penalties. His is…

  • Pharma
  • April 30, 2025
  • 88 views
US FDA approves first cell-based gene therapy for rare genetic skin disorder

The U.S. Food and Drug Administration approved Abeona Therapeutics’ (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn, is approved to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

US FDA approves first cell-based gene therapy for rare genetic skin disorder

US FDA approves first cell-based gene therapy for rare genetic skin disorder

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

Cargologic receives CEIV Pharma re-certification

Cargologic receives CEIV Pharma re-certification